Flowcytometric evidence of platelet activation in patients on aspirin following myocardial infarction

National Medical Journal of India

Volumn 19, Issue 2, 2006, Pages 73-74

  Ghosh, K ^a   Khare, A ^a   Shetty, S ^a   Nair, S ^a   Kulkarni, B ^a   Mohanty, D ^a  

^a KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOGEN; PADGEM PROTEIN;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG DOSE REGIMEN; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PROTEIN BINDING; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; THROMBOCYTE ACTIVATION;

ACUTE DISEASE; ADULT; ASPIRIN; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CYCLOOXYGENASE INHIBITORS; DRUG MONITORING; FEMALE; FIBRINOGEN; FLOW CYTOMETRY; HUMANS; MALE; MYOCARDIAL INFARCTION; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33646846480     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Akimova EV, Bogmat LF. Premature coronary heart disease: The influence of positive family history on platelet activity in vivo in children and adolescents (family study). J Cardiovasc Risk 1997;4:13-18.
2. Nair S, Kulkarni S, Camoens HM, Ghosh K, Mohanty D. Changes in platelet glycoprotein receptors after smoking - a flow cytometric study. Platelets 2001;12: 20-6.
3. Bharucha K, Kulkarni S, Nair S, Ghosh K, Mohanty D, Walvekar V, et al. Functional and fibrinogen receptor studies in platelets in pre-eclamptic toxaemia of pregnancy. Platelets 1999;10:197-202.
4. Malinin AI, Atar D, Callahan KP, McKenzie ME, Serebruany VL. Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease. Eur J Pharmacol 2003;462:139-43.
5. Serebruany VL, Gurbel PA, Shustov AR, Ohman EM, Topol EJ. Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction. Am Heart J 1998;136:398-405.
6. McGill DA, Ardlie NG. Abnormal platelet reactivity in men with premature coronary heart disease. Coron Artery Dis 1994;5:889-900.
7. Deliargyris EN, Boudoulas H. Aspirin resistance. Hellenic J Cardiol 2004;45:1-5.
8. Pulcinelli FM, Pignatelli P, Celestini A, Riondino S, Gazzaniga PP, Violi F. Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients. J Am Coll Cardiol 2004;43:979-84.
9. Homoncik M, Jilma B, Hergovich N, Stohlawetz P, Panzer S, Speiser W. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thromb Haemost 2000;83:316-21.
10. Shimizu M, Yamamoto M, Miyachi H, Shinohara Y, Ando Y. Simple, rapid, and automated method for detection of hyperaggregability of platelets using a hematology analyzer. Am J Hematol 2003;72:282-3.